secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMERICAN VANGUARD CORP (AVD)
CIK:        0000005981
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001193125-24-197961
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

American Vanguard Q2 EPS -$0.42; cuts FY2024 EBITDA guidance to $40-50M; EPA suspends Dacthal
--------------------------------------------------------------------------------

- Net sales $128.2M vs $132.8M Q2; Adj EBITDA $6.2M vs $10.7M; EPS $(0.42) vs $(0.04).
- FY2024 guidance cut: Adj EBITDA now $40-50M (prev. $60-70M); net sales down 2% to flat (prev. +6-9%).
- EPA issued emergency suspension of Dacthal; company had voluntarily paused sales in April 2024.
- New credit agreement relaxes EBITDA covenant through Q3 2025; upsizes excluded charges; increases rates at high leverage.
- Workforce reduced ~4%; seeking partner for SIMPAS; targeting 15% Adj EBITDA margins by 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/5981/000119312524197961/0001193125-24-197961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/5981/000119312524197961/d796763d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-197961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer